Cargando…

Role of Purinome, A Complex Signaling System, In Glioblastoma Aggressiveness

Detalles Bibliográficos
Autores principales:	Giuliani, Patricia, Carluccio, Marzia, Ciccarelli, Renata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892952/ https://www.ncbi.nlm.nih.gov/pubmed/33613296 http://dx.doi.org/10.3389/fphar.2021.632622

Ejemplares similares

The Role of Wnt Signal in Glioblastoma Development and Progression: A Possible New Pharmacological Target for the Therapy of This Tumor
por: Zuccarini, Mariachiara, et al.
Publicado: (2018)

Uncovering the Signaling Pathway behind Extracellular Guanine-Induced Activation of NO System: New Perspectives in Memory-Related Disorders
por: Zuccarini, Mariachiara, et al.
Publicado: (2018)

The Purinome and the preBötzinger Complex – A Ménage of Unexplored Mechanisms That May Modulate/Shape the Hypoxic Ventilatory Response
por: Reklow, Robert J., et al.
Publicado: (2019)

Upregulation of Epithelial-To-Mesenchymal Transition Markers and P2X7 Receptors Is Associated to Increased Invasiveness Caused by P2X7 Receptor Stimulation in Human Glioblastoma Stem Cells
por: Ziberi, Sihana, et al.
Publicado: (2019)

Proteomic Characterization of Two Extracellular Vesicle Subtypes Isolated from Human Glioblastoma Stem Cell Secretome by Sequential Centrifugal Ultrafiltration
por: Di Giuseppe, Fabrizio, et al.
Publicado: (2021)

Investigating the Role of Guanosine on Human Neuroblastoma Cell Differentiation and the Underlying Molecular Mechanisms
por: Belluardo, Natale, et al.
Publicado: (2021)

Multipotent Stromal Cells from Subcutaneous Adipose Tissue of Normal Weight and Obese Subjects: Modulation of Their Adipogenic Differentiation by Adenosine A(1) Receptor Ligands
por: Zuccarini, Mariachiara, et al.
Publicado: (2021)

Guanine inhibits the growth of human glioma and melanoma cell lines by interacting with GPR23
por: Garozzo, Roberta, et al.
Publicado: (2022)

Editorial: Targeting intra- and extracellular signals contributing to cancer stemness and metastasis in aggressive cancers, Volume II
por: Caja, Laia, et al.
Publicado: (2022)

Role of the TSPO–NOX4 axis in angiogenesis in glioblastoma
por: Jiang, Hongxiang, et al.
Publicado: (2022)

Natural Small Molecules Targeting NF-κB Signaling in Glioblastoma
por: Uddin, Md. Sahab, et al.
Publicado: (2021)

Molecular mechanisms of ferroptosis and the potential therapeutic targets of ferroptosis signaling pathways for glioblastoma
por: Zhang, Meng, et al.
Publicado: (2022)

Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling
por: Xu, Jiayun, et al.
Publicado: (2022)

In Search of a Role for Extracellular Purine Enzymes in Bone Function
por: Zuccarini, Mariachiara, et al.
Publicado: (2021)

The Guanine-Based Purinergic System: The Tale of An Orphan Neuromodulation
por: Di Liberto, Valentina, et al.
Publicado: (2016)

Role of PARP Inhibitors in Glioblastoma and Perceiving Challenges as Well as Strategies for Successful Clinical Development
por: Bisht, Priya, et al.
Publicado: (2022)

RETRACTED ARTICLE: Modulation of the TGF-β1-induced epithelial to mesenchymal transition (EMT) mediated by P1 and P2 purine receptors in MDCK cells
por: Zuccarini, Mariachiara, et al.
Publicado: (2017)

Glucose and Amino Acid Metabolic Dependencies Linked to Stemness and Metastasis in Different Aggressive Cancer Types
por: Chisari, Andrea, et al.
Publicado: (2021)

Purinergic Signaling in Oral Tissues
por: Zuccarini, Mariachiara, et al.
Publicado: (2022)

The role of ion channels in the hypoxia-induced aggressiveness of glioblastoma
por: Sforna, Luigi, et al.
Publicado: (2015)

Targeted Nanotechnology in Glioblastoma Multiforme
por: Glaser, Talita, et al.
Publicado: (2017)

Drug Repositioning in Glioblastoma: A Pathway Perspective
por: Tan, Sze Kiat, et al.
Publicado: (2018)

Immune Checkpoint in Glioblastoma: Promising and Challenging
por: Huang, Jing, et al.
Publicado: (2017)

Harnessing Microglia and Macrophages for the Treatment of Glioblastoma
por: Prionisti, Ioanna, et al.
Publicado: (2019)

Antioxidants Attenuate Isolation- and L-DOPA-Induced Aggression in Mice
por: Hira, Sundas, et al.
Publicado: (2018)

Quercetin Suppresses Human Glioblastoma Migration and Invasion via GSK3β/β-catenin/ZEB1 Signaling Pathway
por: Chen, Bo, et al.
Publicado: (2022)

Multiomics integration reveals the effect of Orexin A on glioblastoma
por: Yang, Sha, et al.
Publicado: (2023)

AEG-1–AKT2: A novel complex controlling the aggressiveness of glioblastoma
por: Emdad, Luni, et al.
Publicado: (2015)

The potential of polymeric micelles in the context of glioblastoma therapy
por: Morshed, Ramin A., et al.
Publicado: (2013)

Potential for Nuclear Medicine Therapy for Glioblastoma Treatment
por: Bailly, Clément, et al.
Publicado: (2019)

Glioblastoma Treatments: An Account of Recent Industrial Developments
por: Alphandéry, Edouard
Publicado: (2018)

The PI3K Inhibitor XH30 Enhances Response to Temozolomide in Drug-Resistant Glioblastoma via the Noncanonical Hedgehog Signaling Pathway
por: Ji, Ming, et al.
Publicado: (2021)

Posaconazole inhibits the stemness of cancer stem-like cells by inducing autophagy and suppressing the Wnt/β-catenin/survivin signaling pathway in glioblastoma
por: Wang, Hua, et al.
Publicado: (2022)

Parvifloron D-based potential therapy for glioblastoma: Inducing apoptosis via the mitochondria dependent pathway
por: Magalhães, Mariana, et al.
Publicado: (2022)

CD146 increases stemness and aggressiveness in glioblastoma and activates YAP signaling
por: Liang, Yuanke, et al.
Publicado: (2022)

Apatinib for recurrent/progressive glioblastoma multiforme: A salvage option
por: Zhang, Hong-Hong, et al.
Publicado: (2022)

Alkylaminophenol Induces G1/S Phase Cell Cycle Arrest in Glioblastoma Cells Through p53 and Cyclin-Dependent Kinase Signaling Pathway
por: Doan, Phuong, et al.
Publicado: (2019)

Low FNDC5/Irisin expression is associated with aggressive phenotypes in gastric cancer
por: Xu, Luyun, et al.
Publicado: (2022)

Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment
por: Tang, Lin, et al.
Publicado: (2021)

Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy
por: Yi, Yang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gt9fb5nk9umeccebffsnnp98os